Clinical trial
In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated Plasmodium Falciparum Malaria in Malawi, 2014
NCT02637128 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated Plasmodium Falciparum Malaria in Malawi, 2014
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- July 31, 2014
- Enrollment
- 452 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.